Akia is one of several patients profiled in Novartis' digital campaign to raise awareness around the rare blood disorder ITP.
July 26, 2022 02:44 PM EDTUpdated July 29, 07:23 AM
Pharma
Marketing

Eye-catch­ing pho­tos spot­light pa­tients in No­var­tis’ ITP dig­i­tal and so­cial aware­ness cam­paign

Beth Snyder Bulik

Senior Editor

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

TRENDING NOW

Up­dat­ed: Trump ad­min­is­tra­tion halts more than $750M in funds for Mod­er­na’s bird flu vac­cine

FDA re­jects Stealth's rare dis­ease drug, but of­fers po­ten­tial for ac­cel­er­at­ed ap­proval

A new dawn for psy­che­delics? Com­pass could be the first to find out

Oric locks down cash for Phase 3 prostate can­cer tri­al with ear­ly da­ta in hand

Pep­Gen ditch­es Duchenne pro­grams af­ter mid-stage fail, switch­es to pre­vi­ous­ly halt­ed mus­cle wast­ing ther­a­py

sponsored

From weeks to days: how Aizon In­tel­li­gent Agents trans­form phar­ma val­i­da­tion

A service from the Financial Times